Division of Acquired Immunodeficiency Syndrome (DAIDS)

Overview

The Division of Acquired Immunodeficiency Syndrome (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Specifically, the mission of DAIDS is to help ensure an end to the HIV/AIDS epidemic by increasing basic knowledge of the pathogenesis and transmission of the human immunodeficiency virus (HIV), supporting the development of therapies for HIV infection and its complications and co-infections, and supporting the development of vaccines and other prevention strategies. DAIDS accomplishes this through planning, implementing, managing, and evaluating programs through the following research programs and offices:

1. Basic Sciences Program (BSP) 
2. Therapeutics Research Program (TRP)
3. Vaccine Research Program (VRP) 
4. Prevention Sciences Program (PRP)
5. Office for Policy in Clinical Research Operations (OPCRO)
6. Office of Program Operations and Scientific Information (OPOSI)
7. Office of Clinical Site Oversight (OCSO)